Mustafa Tarık Ağaç
Research Subjects
Mustafa Tarık Ağaç has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
Hakan Erkan
Cardiology Department, Ahi Evren Heart and Vascular Surgery Training and Research Hospital, Çamlık Street, 61187 Trabzon, Turkey
9 shared publicationsLevent Korkmaz
Cardiology Department, Ahi Evren Heart and Vascular Surgery Training and Research Hospital, Çamlık Street, 61187 Trabzon, Turkey
7 shared publicationsZeydin Acar
Department of Cardiology, Ahi Evren Cardiovascular and Thoracic Surgery Training and Research Hospital, Trabzon, Turkey
5 shared publications- Ali Riza Akyuz
Department of Cardiology, University of Health Sciences, Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital, Trabzon, Türkiye
4 shared publications - Ramazan Akdemir
Department of Cardiology, Sakarya University, Training and Research Hospital, Sakarya, Turkey
4 shared publications Şükrü Çelik
Department of Cardiology, Ahi Evren Cardiovascular and Thoracic Surgery Training and Research Hospital, Trabzon, Turkey
3 shared publications
Latest Publications
- Open Access
- 1 July 2025
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 33 (3) , 397-400
Use of an atrial septal defect occluder for the closure of an ascending aorta pseudoaneurysm after coronary artery bypass grafting
An aortic pseudoaneurysm is a rare, but serious condition which can result in life-threatening complications. It is usually caused by previous cardiac surgery, trauma, or infection. Due to the high likelihood of rupture with primary surgical intervention, endovascular closure may be performed as the standard of care in eligible cases. In this article, we present a case of a huge aortic pseudoaneurysm with a wide neck which could safely be closed using an atrial septal occluder.
- 1 July 2025
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 33 (3) , 397-400
Open AccessUse of an atrial septal defect occluder for the closure of an ascending aorta pseudoaneurysm after coronary artery bypass grafting
An aortic pseudoaneurysm is a rare, but serious condition which can result in life-threatening complications. It is usually caused by previous cardiac surgery, trauma, or infection. Due to the high likelihood of rupture with primary surgical intervention, endovascular closure may be performed as the standard of care in eligible cases. In this article, we present a case of a huge aortic pseudoaneurysm with a wide neck which could safely be closed using an atrial septal occluder.
- Open Access
Transcoronary Gradients of Mechanosensitive MicroRNAs as Predictors of Collateral Development in Chronic Total Occlusion
Background and Objectives: In this present study, we investigated the impact of mechanosensitive microRNAs (mechano-miRs) on the collateral development in 126 chronic total occlusion (CTO) patients, selected from 810 undergoing angiography. Materials and Methods: We quantified the collateral blood supply using the collateral flow index (CFI) and assessed the transcoronary mechano-miR gradients. Results: The patients with favorable collaterals had higher CFI values (0.45 ± 0.02) than those with poor collaterals (0.38 ± 0.03, p < 0.001). Significant differences in transcoronary gradients were found for miR-10a, miR-19a, miR-21, miR-23b, miR-26a, miR-92a, miR-126, miR-130a, miR-663, and let7d (p < 0.05). miR-26a and miR-21 showed strong positive correlations with the CFI (r = 0.715 and r = 0.663, respectively), while let7d and miR-663 were negatively correlated (r = −0.684 and r = −0.604, respectively). The correlations between cytokine gradients and mechano-miR gradients were also significant, including Transforming Growth Factor Beta with miR-126 (r = 0.673, p < 0.001) and Vascular Endothelial Growth Factor with miR-10a (r = 0.602, p = 0.002). A regression analysis highlighted the hemoglobin level, smoking, beta-blocker use, miR-26a, and miR-663 as significant CFI determinants, indicating their roles in modulating the collateral vessel development. Conclusions: These findings suggest mechanosensitive microRNAs as predictive biomarkers for collateral circulation, offering new therapeutic perspectives for CTO patients.
Open AccessTranscoronary Gradients of Mechanosensitive MicroRNAs as Predictors of Collateral Development in Chronic Total Occlusion
Background and Objectives: In this present study, we investigated the impact of mechanosensitive microRNAs (mechano-miRs) on the collateral development in 126 chronic total occlusion (CTO) patients, selected from 810 undergoing angiography. Materials and Methods: We quantified the collateral blood supply using the collateral flow index (CFI) and assessed the transcoronary mechano-miR gradients. Results: The patients with favorable collaterals had higher CFI values (0.45 ± 0.02) than those with poor collaterals (0.38 ± 0.03, p < 0.001). Significant differences in transcoronary gradients were found for miR-10a, miR-19a, miR-21, miR-23b, miR-26a, miR-92a, miR-126, miR-130a, miR-663, and let7d (p < 0.05). miR-26a and miR-21 showed strong positive correlations with the CFI (r = 0.715 and r = 0.663, respectively), while let7d and miR-663 were negatively correlated (r = −0.684 and r = −0.604, respectively). The correlations between cytokine gradients and mechano-miR gradients were also significant, including Transforming Growth Factor Beta with miR-126 (r = 0.673, p < 0.001) and Vascular Endothelial Growth Factor with miR-10a (r = 0.602, p = 0.002). A regression analysis highlighted the hemoglobin level, smoking, beta-blocker use, miR-26a, and miR-663 as significant CFI determinants, indicating their roles in modulating the collateral vessel development. Conclusions: These findings suggest mechanosensitive microRNAs as predictive biomarkers for collateral circulation, offering new therapeutic perspectives for CTO patients.
- 18 January 2024
- Published by SAGE Publications in Angiology
- Vol. 76 (6) , 531-537
Increased Cardio-ankle Vascular Index Values in Migraine Patients With Aura
Patients with migraine with aura are at an increased risk of cardiovascular disease. There are limited data on arterial stiffness in migraine patients with aura. The present study evaluated arterial stiffness in these patients using the cardio-ankle vascular index (CAVI). This prospective study included 50 patients with migraine with aura (43 female, mean age 38.9 ± 9.9 years). The patient group was matched for age and gender with 50 healthy individuals with no history of migraine (43 female, mean age 39.3 ± 10.3 years). All patients and control subjects underwent a comprehensive clinical evaluation by an experienced neurologist and were interviewed about their headache histories. There was no significant difference in baseline demographic characteristics and echocardiographic parameters between migraine with aura patients and the control group. Both right and left CAVI values were significantly higher in the patients with migraine with aura (6.5 ± 1.2 vs 6.1 ± 0.7, P = .043 and 6.6 ± 1.2 vs 6.1 ± 0.7, P = .009, respectively). Arterial stiffness is an important mediator of cardiovascular diseases. We found that CAVI, a novel marker of the arterial stiffness, is increased in patients with migraine with aura.
- 18 January 2024
- Published by SAGE Publications in Angiology
- Vol. 76 (6) , 531-537
Increased Cardio-ankle Vascular Index Values in Migraine Patients With Aura
Patients with migraine with aura are at an increased risk of cardiovascular disease. There are limited data on arterial stiffness in migraine patients with aura. The present study evaluated arterial stiffness in these patients using the cardio-ankle vascular index (CAVI). This prospective study included 50 patients with migraine with aura (43 female, mean age 38.9 ± 9.9 years). The patient group was matched for age and gender with 50 healthy individuals with no history of migraine (43 female, mean age 39.3 ± 10.3 years). All patients and control subjects underwent a comprehensive clinical evaluation by an experienced neurologist and were interviewed about their headache histories. There was no significant difference in baseline demographic characteristics and echocardiographic parameters between migraine with aura patients and the control group. Both right and left CAVI values were significantly higher in the patients with migraine with aura (6.5 ± 1.2 vs 6.1 ± 0.7, P = .043 and 6.6 ± 1.2 vs 6.1 ± 0.7, P = .009, respectively). Arterial stiffness is an important mediator of cardiovascular diseases. We found that CAVI, a novel marker of the arterial stiffness, is increased in patients with migraine with aura.
- Open Access
- 1 January 2024
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 28 (4) , 215
Reply to Letter to the Editor: “A Modified Medina and Movahed (3M) Classification of Coronary Bifurcation Lesions’’
- 1 January 2024
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 28 (4) , 215
Open AccessReply to Letter to the Editor: “A Modified Medina and Movahed (3M) Classification of Coronary Bifurcation Lesions’’
- 12 January 2022
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 15 (3) , e27-e29
A Novel Closed-Loop Balloon-Stent Technique for Vessel Closure
- 12 January 2022
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 15 (3) , e27-e29
A Novel Closed-Loop Balloon-Stent Technique for Vessel Closure
- Open Access
- 29 October 2021
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 3 (4) , 156-163
The relationship between coronary artery disease and hs-troponin T changing during exercise stress test
Background The aim of this study was to investigate the relationship between coronary artery disease and changing of high sensitivity troponin T (hs-TnT) values during exercise stress test (EST) in patients with suspected coronary artery disease. Material and Methods We included 68 patients who underwent coronary angiography after positive EST. The hs-TnT values of all patients were measured before EST and at 4 hours after EST. Patients with coronary artery stenosis of 50% or more were divided into two groups [CAD (+)] and those without [CAD (-)].hs-TnT values measured before and after EST were compared. Results Among the 68 patients evaluated, 26 patients (39.3%) were identified as CAD (-) and 42 patients (61.7) as CAD (+).There was no significant difference between the two groups in the hs-TnT values before and after EST. There was a significant correlation between hs-TnT before exercise and pre-EST systolic blood pressure (SBP) (r = 0.313, p = 0.009) and hs-TnT before exercise and peak SBP during EST (r=0.241, p=0.038), anda also we found a correlation between hs-TnT after EST and peak SBP during EST (r = 0.398, p = 0.001). However, a strong negative correlation was found between the Duke treadmill score (DTS) calculated by the exercise test parameters and the Syntax score, which indicates the extent and severity of coronary artery disease (r =-0.521, p = 0.0001). Conclusions As a result of our study, it was observed that hs-TnT values did not contribute to the diagnosis of coronary artery disease. However, DTS evaluation performed before invasive coronary angiography can provide important information about coronary artery lesion complexity.
- 29 October 2021
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 3 (4) , 156-163
Open AccessThe relationship between coronary artery disease and hs-troponin T changing during exercise stress test
Background The aim of this study was to investigate the relationship between coronary artery disease and changing of high sensitivity troponin T (hs-TnT) values during exercise stress test (EST) in patients with suspected coronary artery disease. Material and Methods We included 68 patients who underwent coronary angiography after positive EST. The hs-TnT values of all patients were measured before EST and at 4 hours after EST. Patients with coronary artery stenosis of 50% or more were divided into two groups [CAD (+)] and those without [CAD (-)].hs-TnT values measured before and after EST were compared. Results Among the 68 patients evaluated, 26 patients (39.3%) were identified as CAD (-) and 42 patients (61.7) as CAD (+).There was no significant difference between the two groups in the hs-TnT values before and after EST. There was a significant correlation between hs-TnT before exercise and pre-EST systolic blood pressure (SBP) (r = 0.313, p = 0.009) and hs-TnT before exercise and peak SBP during EST (r=0.241, p=0.038), anda also we found a correlation between hs-TnT after EST and peak SBP during EST (r = 0.398, p = 0.001). However, a strong negative correlation was found between the Duke treadmill score (DTS) calculated by the exercise test parameters and the Syntax score, which indicates the extent and severity of coronary artery disease (r =-0.521, p = 0.0001). Conclusions As a result of our study, it was observed that hs-TnT values did not contribute to the diagnosis of coronary artery disease. However, DTS evaluation performed before invasive coronary angiography can provide important information about coronary artery lesion complexity.
- 3 February 2021
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 43 (4) , 349-355
Cardio-ankle vascular index represents the best surrogate for 10-year ASCVD risk estimation in patients with primary hypertension
Background: Identification of target organ damage and/or risk-enhancing factors help treatment decisions in hypertensive and hyperlipidaemic patients who reside in borderline to an intermediate risk category based on 10-year atherosclerotic cardiovascular disease (ASCVD) risk estimates. Aim: In the present study, we aimed to investigate the comparative efficacy of certain hypertension-mediated organ damage markers (HMOD) for the prediction of 10-year ASCVD risk ≥10%, in patients with primary hypertension without established CVD. Methods: One-hundred thirty-seven asymptomatic hypertensive patients ≥40 years of age were enrolled in the present study. Ten-year ASCVD risks were estimated by Pooled Cohort Equations. The following HMOD markers; pulse pressure (PP), left ventricular mass index (LVMI), carotid intima-media thickness (CIMT), ankle-brachial index (ABI), cardio-ankle vascular index (CAVI) and estimated glomerular filtration rate (eGFR) were evaluated with respect to efficacy for predicting ≥10% ASCVD risk with ROC analysis. Results: CAVI gave the greatest Area Under Curve (AUC = 0.736, p < .000), and followed by CIMT (AUC = 0.727, p < .000), LVMI (AUC = O.630, p = .01), and PP (AUC = 0.623, p = .02). ABI and eGFR were not found to be predictive. CAVI correlated best with estimated 10-year ASCVD risk (r = 0.460, p < .000). A CAVI value ≥8 was found 71% sensitive and 72% specific for predicting ≥10% risk in 10-year ASCVD risk scale. CAVI gave the best graded response to increments in 10-year ASCVD risk categories. Conclusion: We suggest that CAVI is the best surrogate for 10-year ASCVD risk, among several HMOD markers.
- 3 February 2021
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 43 (4) , 349-355
Cardio-ankle vascular index represents the best surrogate for 10-year ASCVD risk estimation in patients with primary hypertension
Background: Identification of target organ damage and/or risk-enhancing factors help treatment decisions in hypertensive and hyperlipidaemic patients who reside in borderline to an intermediate risk category based on 10-year atherosclerotic cardiovascular disease (ASCVD) risk estimates. Aim: In the present study, we aimed to investigate the comparative efficacy of certain hypertension-mediated organ damage markers (HMOD) for the prediction of 10-year ASCVD risk ≥10%, in patients with primary hypertension without established CVD. Methods: One-hundred thirty-seven asymptomatic hypertensive patients ≥40 years of age were enrolled in the present study. Ten-year ASCVD risks were estimated by Pooled Cohort Equations. The following HMOD markers; pulse pressure (PP), left ventricular mass index (LVMI), carotid intima-media thickness (CIMT), ankle-brachial index (ABI), cardio-ankle vascular index (CAVI) and estimated glomerular filtration rate (eGFR) were evaluated with respect to efficacy for predicting ≥10% ASCVD risk with ROC analysis. Results: CAVI gave the greatest Area Under Curve (AUC = 0.736, p < .000), and followed by CIMT (AUC = 0.727, p < .000), LVMI (AUC = O.630, p = .01), and PP (AUC = 0.623, p = .02). ABI and eGFR were not found to be predictive. CAVI correlated best with estimated 10-year ASCVD risk (r = 0.460, p < .000). A CAVI value ≥8 was found 71% sensitive and 72% specific for predicting ≥10% risk in 10-year ASCVD risk scale. CAVI gave the best graded response to increments in 10-year ASCVD risk categories. Conclusion: We suggest that CAVI is the best surrogate for 10-year ASCVD risk, among several HMOD markers.
- 1 January 2021
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 13 (3) , 628-633
Systolic Blood Pressure Variability and Its Relationship with Surrogate Markers of Cardiovascular Risk in Hypertensive Patients
Objective: Systolic blood pressure variability (SBPV) is a measure of oscillations in SBP for 24 hours. There are conflicting data about the relationship between SBPV and cardiovascular (CV) diseases. In this study we aim to document relationship between SBPV and surrogate markers of CV damage in a hypertensive patient cohort. Methods: Previously documented hypertension patients were enrolled. Patients with previous documented CV disease, diabetes mellitus and secondary hypertension were excluded. 24-hour ambulatory blood pressure monitoring (ABPM), echocardiography, electrocardiography and cardio-ankle vascular index (CAVI) measurements were performed. SBPV is defined as standard deviation of mean systolic blood pressure readings from ABMP records. The relationship between SBPV and QTc distance, QT dispersion, presence of fragmented QRS, CAVI results were examined. Results: 64 patients were enrolled square mean age 50 square 8, 24(37%) were male]. Mean SBPV was 15.12 square 4.6 mmHg and there was not a significant correlation between SBPV CAVI, QTc measurements of the study patients but there was a significant positive correlation with QT dispersion values (28.6 square 15.2 msec, p=0.004, p=0.354). When patients were divided into two categories as high SBPV and low SBPV, QT dispersion was consistently longer in high SBPV group (p=0.006). Conclusions: In hypertensive patients without documented CV disease and signs of hypertensive CV changes on clinical evaluation, SBPV is positively correlated with QT dispersion but high SBPV is not related with aortic stiffness according to CAVI results. These findings might be a sign of occult left ventricular fibrosis and high risk of arrhythmia in hypertensive patients with high SBPV.
- 1 January 2021
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 13 (3) , 628-633
Systolic Blood Pressure Variability and Its Relationship with Surrogate Markers of Cardiovascular Risk in Hypertensive Patients
Objective: Systolic blood pressure variability (SBPV) is a measure of oscillations in SBP for 24 hours. There are conflicting data about the relationship between SBPV and cardiovascular (CV) diseases. In this study we aim to document relationship between SBPV and surrogate markers of CV damage in a hypertensive patient cohort. Methods: Previously documented hypertension patients were enrolled. Patients with previous documented CV disease, diabetes mellitus and secondary hypertension were excluded. 24-hour ambulatory blood pressure monitoring (ABPM), echocardiography, electrocardiography and cardio-ankle vascular index (CAVI) measurements were performed. SBPV is defined as standard deviation of mean systolic blood pressure readings from ABMP records. The relationship between SBPV and QTc distance, QT dispersion, presence of fragmented QRS, CAVI results were examined. Results: 64 patients were enrolled square mean age 50 square 8, 24(37%) were male]. Mean SBPV was 15.12 square 4.6 mmHg and there was not a significant correlation between SBPV CAVI, QTc measurements of the study patients but there was a significant positive correlation with QT dispersion values (28.6 square 15.2 msec, p=0.004, p=0.354). When patients were divided into two categories as high SBPV and low SBPV, QT dispersion was consistently longer in high SBPV group (p=0.006). Conclusions: In hypertensive patients without documented CV disease and signs of hypertensive CV changes on clinical evaluation, SBPV is positively correlated with QT dispersion but high SBPV is not related with aortic stiffness according to CAVI results. These findings might be a sign of occult left ventricular fibrosis and high risk of arrhythmia in hypertensive patients with high SBPV.
- Open Access
- 1 February 2019
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 21 (2) , 76-82
Is endocan a biochemical marker for asymptomatic target organ damage in hypertensive patients?
Objective: Identification of the asymptomatic target organ damage MOD) helps to stratify the overall risk of cardiovascular (CV) diseases and guides a treatment decision in hypertensive patients without a symptomatic CV or renal disease. The endothelial-cell-specific molecule 1 (endocan) is regarded as a novel marker of endothelial dysfunction. Its release is increased in hypertensive patients, especially those with symptomatic CV and renal disease. In the present study, we aimed to evaluate the endocan levels in asymptomatic hypertensive patients with or without AOD. Methods: The study included 132 asymptomatic hypertensive patients, and 101 of who had at least one AOD. Results: Serum endocan levels did not differ between patients with and without AOD (3.81 +/- 0.78 vs. 3.83 +/- 0.63 ng/mL, p=0.88). An analysis according to the presence of any specific AOD did not show any difference between groups. No significant correlation was found between serum endocan levels and any of the continuous variables related to AOD, such as the pulse pressure, carotid intimae-media thickness, cardio-ankle vascular index, ankle-brachial index, left ventricular mass index, Sokolow-Lyon index, Cornell voltage-duration product, and estimated glomerular filtration rate. Conclusion: Endocan may not serve as a useful biomarker at asymptomatic vascular stages of hypertension, despite its role in indicating disease severity and inflammatory activation in advanced symptomatic CV and renal disease.
- 1 February 2019
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 21 (2) , 76-82
Open AccessIs endocan a biochemical marker for asymptomatic target organ damage in hypertensive patients?
Objective: Identification of the asymptomatic target organ damage MOD) helps to stratify the overall risk of cardiovascular (CV) diseases and guides a treatment decision in hypertensive patients without a symptomatic CV or renal disease. The endothelial-cell-specific molecule 1 (endocan) is regarded as a novel marker of endothelial dysfunction. Its release is increased in hypertensive patients, especially those with symptomatic CV and renal disease. In the present study, we aimed to evaluate the endocan levels in asymptomatic hypertensive patients with or without AOD. Methods: The study included 132 asymptomatic hypertensive patients, and 101 of who had at least one AOD. Results: Serum endocan levels did not differ between patients with and without AOD (3.81 +/- 0.78 vs. 3.83 +/- 0.63 ng/mL, p=0.88). An analysis according to the presence of any specific AOD did not show any difference between groups. No significant correlation was found between serum endocan levels and any of the continuous variables related to AOD, such as the pulse pressure, carotid intimae-media thickness, cardio-ankle vascular index, ankle-brachial index, left ventricular mass index, Sokolow-Lyon index, Cornell voltage-duration product, and estimated glomerular filtration rate. Conclusion: Endocan may not serve as a useful biomarker at asymptomatic vascular stages of hypertension, despite its role in indicating disease severity and inflammatory activation in advanced symptomatic CV and renal disease.